Continued Confidence on HeartMate II Following Field Check Update
JMP Securities reports destination therapy referrals are off to a stronger than expected start, leading to predictions that the market should be the next growth engine for Thoratec.
JMP Securities reports destination therapy referrals are off to a stronger than expected start, leading to predictions that the market should be the next growth engine for Thoratec.